Healthcare | March 22, 2022
M2 milk platform to develop cell-cultured milk
Building the future of food in the birthplace of cell-cultured milk
Building the future of food in the birthplace of cell-cultured milk
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Enables millions of Indians to monitor their vitals without the need of any additional device
Subscribe To Our Newsletter & Stay Updated
